Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis
Article Properties
-
DOI (url)
-
Publication Date2019/03/01
-
Journal
-
Indian UGC (journal)
-
Citations3
-
Miraç Ayşen Ünsal
Cite
Ünsal, Miraç Ayşen. “Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis”. Turkish Journal Of Neurology, vol. 25, no. 1, 2019, pp. 50-51, https://doi.org/10.4274/tnd.2019.00187.
Ünsal, M. A. (2019). Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis. Turkish Journal Of Neurology, 25(1), 50-51. https://doi.org/10.4274/tnd.2019.00187
Ünsal MA. Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple Sclerosis. Turkish Journal Of Neurology. 2019;25(1):50-1.
Journal Category
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Neurology
Diseases of the nervous system
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Having Multiple Sclerosis from Childhood to Youth According to Uncertainty Theory: A Case Report | Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi | 2023 | ||
| Defining the experiences of adolescent patients with multiple sclerosis in transition from pediatric care to adult care | Multiple Sclerosis and Related Disorders |
| 2 | 2022 |
Retrospective Evaluation of Demographic and Clinical Characteristics of Children with Multiple Sclerosis | Kocaeli Üniversitesi Sağlık Bilimleri Dergisi | 2022 |
Citations Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 1
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Defining the experiences of adolescent patients with multiple sclerosis in transition from pediatric care to adult care and was published in 2022. The most recent citation comes from a 2023 study titled Having Multiple Sclerosis from Childhood to Youth According to Uncertainty Theory: A Case Report. This article reached its peak citation in 2022, with 2 citations. It has been cited in 3 different journals. Among related journals, the Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi cited this research the most, with 1 citations. The chart below illustrates the annual citation trends for this article.